Improving Health of People with Intellectual Disabilities Program

by: Iola Bonggay

The Centers for Disease Control and Prevention, otherwise referred to as CDC, is a federal government agency operating within the United States Department of Health and Human Services that is greatly responsible for protecting public health and safety through the provision of information to enhance health decisions and the promotion of health through partnerships with state health departments and other organizations.

The grants and initiatives of the CDC are all geared towards the realization of its general agency mission which is to collaborate with other agencies "to create the expertise, information, and tools that people and communities need to protect their health – through health promotion, prevention of disease, injury and disability, and preparedness for new health threats."

In keeping with this mission, the Centers for Disease Control and Prevention has constituted the Improving Health of People with Intellectual Disabilities Program in an attempt to financially support initiatives for people suffering from intellectual disabilities, thereby seeking to increase healthy behaviors and improve access to appropriate health services.

The program also intends to identify comorbid conditions and a number of poor healthy behaviors in people with intellectual disability (ID) to in order to somehow find a way to reduce or totally eliminate these behaviors and make way for better health practices.

Initially, the program is set to focus primarily on US populations but could also extend its activities internationally. By the end of the tenure of the grant, the recipient should have accomplished the following program objectives:

a) Provide health assessments, referral to services, and education to people with ID;

b) Provide health promotion training, information, and encouragement to people with ID and, when appropriate, their caregivers or service providers;

c) Train health care professionals to develop improved skills in their care of people with ID;

  (continued...)

Improving Health of People with Intellectual Disabilities Program
  Page 2

About The Author Iola Bonggay is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs. She also maintains Websites providing resources on environmental grants and grants for youth programs.

Additional Resources

category - Health Grants

Department of Agriculture: Value Added Producer Grants
The Value-Added Producer Grants program is geared towards helping the Independent Producers of Agricultural Commodities, Agriculture Producer Groups, Farmer and Rancher Cooperatives, and Majority-Controlled Producer-Based Business Ventures in developing techniques that would create marketing opportunities and establish business plans involving viable marketing opportunities that involve the production of bio-based products from agricultural commodities.

---

Research to Advance Vaccine Safety Program
The Centers for Disease Control and Prevention has partnered with the National Institutes of Health and as a result, has developed the Research to Advance Vaccine Safety Program, wherein it seeks to obtain a more thorough understanding vaccine safety.

---

Clinical Trials for Organ Transplantation in Children Program
The National Insitutes of Health has formed a partnership with the National Institute of Allergy and Infectious Diseases (NIAID) to establish the Clinical Trials for Organ Transplantation in Children Program wherein both agencies intend to support a group of investigators in their quest of conducting clinical trials regarding pediatric solid organ transplant recipients.

---

Development of Therapeutics and Diagnostics for Biodefense Program
The National Institutes of Health, in partnership with the National Institute of Allergy and Infectious Diseases(NIAID), has established the Development of Therapeutics and Diagnostics for Biodefense Program in an attempt to seek research proposals that desire to support the development of lead candidate diagnostics or therapeutics against NIAID Category A, B, or C priority agents.

---